title: [Behavior research of allergic rhinitis with adenoid hypertrophy in children].
abstract: OBJECTIVE
  To investigate the behavior difference of allergic rhinitis with adenoid hypertrophy between study group and control group.
  
  
  METHODS
  One hundred and seventeen children diagnosed as allergic rhinitis with adenoid hypertrophy were enrolled in our study were divided into study group and control group. Forty-two children treated with local steroid nasal spray for two to three months and antihistamine were control group. Seventy-five children treated with endoscopic adenoidectomy and drug treatment were study group; All children' parents were inquired for their clinical presentation.
  
  
  RESULTS
  No distinctive differences were found between the two groups (P > 0.05) in adenoid hypertrophy, accompanying nasal problems and clinical questionnaire scoring. Significant statistical distinction were found (P < 0.05) in snoring, sleep disturbance and frequent arousal, nasal obstructive moth-breathing, and recurrent respiratory tract infection between the two groups after three-month follow up.
  
  
  CONCLUSIONS
  Endoscopic adenoidectomy should be taken into account for allergic rhinitis with adenoid hypertrophy in children. Adenoidectomy would be useful for the improvement of behavior symptoms.
authors.affiliation: Department of Otorhinolaryngology, Hunan Children' s Hospital, Changsha, 410007, China.
authors.forename: Yunlong
authors.initials: Y
authors.lastname: Jing
authors.forename: Binya
authors.initials: B
authors.lastname: Hu
authors.forename: Jing
authors.initials: J
authors.lastname: Huang
authors.forename: Sijun
authors.initials: S
authors.lastname: Zhao
authors.forename: Lihua
authors.initials: L
authors.lastname: Tao
authors.forename: Xiangyue
authors.initials: X
authors.lastname: Peng
mesh_terms: D000233:Adenoidectomy / Q000379:methods*; D000234:Adenoids / Q000473:pathology*; D018926:Anti-Allergic Agents / Q000008:administration & dosage; D016022:Case-Control Studies; D002648:Child; D003131:Combined Modality Therapy; D004724:Endoscopy; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006801:Humans; D006984:Hypertrophy / Q000150:complications / Q000628:therapy; D008297:Male; D065631:Rhinitis, Allergic / Q000150:complications / Q000628:therapy*; D013256:Steroids / Q000008:administration & dosage
chemical_list: D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D013256:Steroids